Controlling the uncontrollable - resistant hypertension and the role of aldosterone

Professor Michel Azizi on aldosterone receptor blocker versus aldosterone synthase inhibitor. Who is more effective in blocking aldosterone?

Management of older hypertensive patients

Professor Athanase Benetos on how to take care and treat hypertensive older people.

ESH guidelines 2023: a new light on beta-blockers in hypertension

Professor Giuseppe Mancia on the update of ESH guidelines 2023.

ESH - ESC HFA Joint meeting: HFpEF update 2024

Professor Enrico Agabiti Rosei on heart failure with preserved ejection fraction updates at ESH 2024.

2023 ESH Hypertension Guideline Update

Combination of a beta-blocker with calcium channel blocker in hypertension

Professor Gianfranco Parati share his thoughts on combination of a beta-blocker with calcium channel blocker in hypertension.

ESH Clinical Practice Guidelines

Professor Roland Schmieder, Co-Chair of ESH 2024 on the ESH 2024 Congress and the updated Guidelines.

Nephroprotection using SGLT2 inhibitors in patients with hypertension

Professor Michael Böhm on evolving standard of care and SGLT2 inhibitors for patients with CKD and hypertension.

Diabetes and Metabolic risk factors

Professor Josep Redon chaired an interesting session on Diabetes and Metabolic risk factors at ESH 2024.

Beta-blockers in hypertension and CVD

Professor Ricardo Fontes-Carvalho on the role of beta-blockers in the treatment of hypertension and cardiologic diseases.

ESH - ISH Joint Session: Balancing common side effects of Thiazide/Thiazide-like diuretics through addition of other Blood Pressure lowering drugs

Professor Jorie Versmissen and Professor Fadi Charchar discussed the ESH - ISH Joint Session on balancing common side effects of Thiazide/Thiazide-like diuretics through addition of other Blood Pressure lowering drugs.

How lifestyle affects hypertension

Professor Fadi Charchar on how lifestyle affects hypertension and what a patient could do to prevent hypertension and reduce then blood pressure.

Overcoming the resistance - Is renal denervation the solution?

Professor Konstantinos Tsioufis shares his thoughts on the novelties of kidney protection in hypertension.

Hypertension and beta-blocker choice: influence of age, stress, and co-morbidities

Professor Sverre Erik Kjeldsen at the recent annual meeting of the European Society of Hypertension, held a lecture on the role of beta-blockers in the management of hypertension.

Effect of renal denervation on blood pressure in patients with chronic kidney disease and uncontrolled hypertension

Professor Roland Schmieder on the results of a prospective randomized sham-controlled study and explains the effects of renal denervation on blood pressure in patients with chronic kidney disease and uncontrolled hypertension

Obesity induced hypertension

Professor Vasilios Kotsis on obesity induced hypertension and its state of the art treatment.